IDXXIDEXX LABORATORIES INC /DEvs its industry peers
A metric-by-metric comparison of IDEXX LABORATORIES INC /DE against Health Care Select Sector SPDR Fund holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IDXXEsta | $43.4B#16 | 38.8x#9 | 26.9x#14 | 10.1x#13 | 10.4%#4 | 19.3%#8 | 31.6%#5 | 65.7%#2 | 58.3%#1 | 9#1 | — | — |
| LLY | $1.33T#1 | 46.0x#12 | 33.1x#15 | 20.5x#16 | 44.7%#1 | 94.9%#4 | 40.2%#1 | 51.3%#4 | 24.8%#4 | — | 68.5%#2 | 0.4%#12 |
| JNJ | $657.8B#2 | 41.5x#11 | 8.1x#8 | 7.0x#10 | 6.0%#9 | 90.6%#5 | 22.9%#9 | 32.9%#7 | 16.3%#8 | 6#3 | 47.3%#4 | 1.9%#10 |
| ABBV | $521.0B#3 | 83.3x#14 | — | 8.5x#12 | 8.6%#7 | -1.2%#11 | 24.6%#8 | — | 18.6%#7 | — | 32.0%#8 | 2.2%#4 |
| UNH | $365.2B#5 | 26.2x#3 | 11.1x#11 | 0.8x#2 | 11.8%#3 | -16.3%#14 | 4.2%#15 | 36.5%#6 | 21.3%#6 | — | — | 2.2%#7 |
| MRK | $368.9B#4 | 119.6x#15 | 8.8x#9 | 5.7x#6 | 1.3%#14 | 6.6%#9 | 34.2%#3 | 43.5%#5 | 21.6%#5 | — | 77.1%#1 | 2.2%#6 |
| AMGN | $252.0B#7 | 29.0x#4 | 21.6x#13 | 6.9x#9 | 10.0%#5 | 88.5%#6 | 24.7%#7 | 66.0%#1 | 15.1%#9 | — | 62.9%#3 | 2.0%#8 |
| TMO | $258.2B#6 | 36.8x#7 | 4.7x#5 | 5.8x#7 | 3.9%#11 | 6.0%#10 | 17.4%#13 | 12.3%#12 | 10.2%#11 | — | 25.6%#9 | 0.2%#13 |
| ABT | $185.1B#9 | 29.8x#5 | 3.6x#4 | 4.2x#5 | 5.7%#10 | -51.3%#15 | 18.2%#12 | 12.5%#11 | 8.3%#12 | — | -12.9%#12 | 2.2%#5 |
| GILD | $212.0B#8 | — | 16.3x#12 | 7.2x#11 | 2.4%#13 | 1672.9%#1 | 34.0%#4 | 65.3%#3 | 25.7%#2 | — | 47.1%#5 | 1.9%#9 |
| ISRG | $149.8B#12 | 52.3x#13 | 9.4x#10 | 14.9x#15 | 20.5%#2 | 23.0%#7 | 29.3%#6 | 17.9%#10 | — | — | — | — |
| PFE | $173.8B#10 | 40.1x#10 | 2.0x#2 | 2.8x#4 | -1.6%#16 | -3.2%#12 | 16.3%#14 | 9.1%#13 | 6.9%#13 | — | 32.6%#7 | 5.6%#1 |
| CVS | $115.4B#15 | 23.8x#2 | 1.4x#1 | 0.3x#1 | 7.8%#8 | -61.7%#16 | 1.2%#16 | 2.2%#15 | 2.9%#15 | 6#3 | 21.1%#10 | 2.9%#3 |
| VRTX | $141.7B#13 | 32.6x#6 | 7.0x#7 | 11.8x#14 | 8.9%#6 | 838.1%#2 | 34.8%#2 | 19.5%#9 | 25.0%#3 | — | — | — |
| DHR | $163.4B#11 | 38.1x#8 | 3.0x#3 | 6.7x#8 | 2.9%#12 | -7.3%#13 | 19.1%#11 | 6.7%#14 | 5.4%#14 | 5#5 | 8.6%#11 | 0.5%#11 |
| BMY | $127.7B#14 | 13.9x#1 | 5.5x#6 | 2.6x#3 | -0.2%#15 | 178.8%#3 | 21.8%#10 | 30.1%#8 | 14.0%#10 | 7#2 | 42.3%#6 | 4.0%#2 |
Peer set: top holdings of XLV (Health Care Select Sector SPDR Fund), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-11-01.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice